Home3371 • FRA
add
Corbus Pharmaceuticals Holdings Inc
Previous close
€7.45
Day range
€7.60 - €7.60
Year range
€3.86 - €18.40
Market cap
152.71M USD
Avg Volume
7.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.91M | 57.29% |
Net income | -23.34M | -69.35% |
Net profit margin | — | — |
Earnings per share | -1.90 | -65.22% |
EBITDA | -24.37M | -58.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.98M | -34.75% |
Total assets | 109.51M | -33.29% |
Total liabilities | 17.37M | 27.02% |
Total equity | 92.15M | — |
Shares outstanding | 17.55M | — |
Price to book | 1.01 | — |
Return on assets | -52.04% | — |
Return on capital | -58.80% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -23.34M | -69.35% |
Cash from operations | -15.55M | -11.53% |
Cash from investing | 19.64M | 227.81% |
Cash from financing | 2.85M | -88.62% |
Net change in cash | 6.94M | 262.77% |
Free cash flow | -7.30M | 21.26% |
About
Founded
Jan 1, 2009
Website
Employees
28
